{"id":"https://openalex.org/W46144748","doi":null,"title":"[Enoxaparin-induced cutaneous necrosis localized on insulin lipodystrophies].","display_name":"[Enoxaparin-induced cutaneous necrosis localized on insulin lipodystrophies].","publication_year":1997,"publication_date":"1997-01-01","ids":{"openalex":"https://openalex.org/W46144748","mag":"46144748","pmid":"https://pubmed.ncbi.nlm.nih.gov/9739898"},"language":"fr","primary_location":{"id":"pmid:9739898","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9739898","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales de dermatologie et de venereologie","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017085711","display_name":"I Lefebvre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155195","display_name":"H\u00f4pital Claude Huriez","ror":"https://ror.org/05cpv3t46","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018718406","https://openalex.org/I4210155195"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"I Lefebvre","raw_affiliation_strings":["Clinique Dermatologique, H\u00f4pital Claude Huriez, CHRU Lille"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinique Dermatologique, H\u00f4pital Claude Huriez, CHRU Lille","institution_ids":["https://openalex.org/I4210155195"]}]},{"author_position":"middle","author":{"id":null,"display_name":"E Delaporte","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Delaporte","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057298043","display_name":"Yves Dejobert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Dejobert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038723800","display_name":"Benoit Catteau","orcid":"https://orcid.org/0000-0001-6310-5000","observed_orcids":["https://orcid.org/0000-0001-6310-5000"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Catteau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"F Piette","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F Piette","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5016148444","display_name":"H Bergoend","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Bergoend","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2066,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.4891945,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"124","issue":"5","first_page":"397","last_page":"400"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.9496999979019165,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14126","display_name":"Intramuscular injections and effects","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.008799999952316284,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enoxaparin","display_name":"enoxaparin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/skin-necrosis","display_name":"skin necrosis","score":0.8820000290870667},{"id":"https://openalex.org/keywords/low-molecular-weight-heparin","display_name":"low molecular weight heparin","score":0.8999999761581421},{"id":"https://openalex.org/keywords/leukocytoclastic-vasculitis","display_name":"leukocytoclastic vasculitis","score":0.9580000042915344},{"id":"https://openalex.org/keywords/type-iii-hypersensitivity","display_name":"type III hypersensitivity","score":0.902999997138977},{"id":"https://openalex.org/keywords/insulin-injection-site","display_name":"insulin injection site","score":0.3540000021457672}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8032197952270508},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.6935141086578369},{"id":"https://openalex.org/C2780439664","wikidata":"https://www.wikidata.org/wiki/Q7535376","display_name":"Skin biopsy","level":3,"score":0.6069271564483643},{"id":"https://openalex.org/C2776015282","wikidata":"https://www.wikidata.org/wiki/Q644318","display_name":"Vasculitis","level":3,"score":0.6065120697021484},{"id":"https://openalex.org/C2776884760","wikidata":"https://www.wikidata.org/wiki/Q2750727","display_name":"Low molecular weight heparin","level":3,"score":0.5534913539886475},{"id":"https://openalex.org/C2780941825","wikidata":"https://www.wikidata.org/wiki/Q1538213","display_name":"Lipodystrophy","level":5,"score":0.5040558576583862},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.5024030208587646},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.46139928698539734},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4569357931613922},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.43610674142837524},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.39733925461769104},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3040376603603363},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2907646894454956},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2776104807853699},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1279950737953186},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.0},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008060","descriptor_name":"Lipodystrophy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008060","descriptor_name":"Lipodystrophy","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009336","descriptor_name":"Necrosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012882","descriptor_name":"Skin Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017984","descriptor_name":"Enoxaparin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017984","descriptor_name":"Enoxaparin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018366","descriptor_name":"Vasculitis, Leukocytoclastic, Cutaneous","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D018366","descriptor_name":"Vasculitis, Leukocytoclastic, Cutaneous","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9739898","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9739898","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales de dermatologie et de venereologie","raw_type":"Case Reports"},{"id":"mag:46144748","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9739898","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4385443545","https://openalex.org/W137554125","https://openalex.org/W4385934717","https://openalex.org/W7214188312","https://openalex.org/W2020974039","https://openalex.org/W2016121591","https://openalex.org/W4224043851","https://openalex.org/W2044224977","https://openalex.org/W2126637025","https://openalex.org/W4247845709"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Low-molecular":[1],"weight":[2,98,149],"heparin-induced":[3],"cutaneous":[4,144],"necrosis":[5,37,145],"is":[6],"exceptional.":[7],"Pathogenesis":[8],"remains":[9],"unclear.":[10],"We":[11],"report":[12],"an":[13,73,109,124,191],"exceptional":[14],"case":[15],"with":[16,95,108,157,190],"elective":[17],"localization":[18,197],"of":[19,35,50,75,143,185,198,209],"the":[20,48,58,66,182,186,199,213],"necrotic":[21,200],"areas":[22,34,43,56,71,201],"in":[23,103,113,123,212,217],"insulin":[24,63,76,125],"lipodystrophic":[25,105,126,218],"tissue.":[26],"CASE":[27],"REPORT:":[28],"A":[29],"69-year":[30],"old":[31],"patient":[32,59],"developed":[33],"skin":[36,55],"after":[38],"starting":[39],"enoxaparin":[40,110,122],"therapy.":[41],"These":[42,70],"were":[44,84,93],"located":[45],"far":[46],"from":[47],"points":[49],"injection":[51],"and":[52,100],"focalized":[53],"on":[54],"where":[57],"had":[60,72],"been":[61,152],"injecting":[62],"daily":[64],"for":[65,121],"last":[67],"four":[68],"years.":[69],"aspect":[74,184],"lipodystrophy.":[77],"Biopsy":[78],"specimens":[79],"showed":[80],"leukocytoclastic":[81,138,183],"vasculitis.":[82,139],"There":[83],"no":[85],"associated":[86],"biological":[87],"anomalies.":[88],"One":[89],"month":[90],"later,":[91],"prick-tests":[92],"made":[94],"different":[96],"low-molecular":[97,148],"heparins":[99],"calcium":[101],"heparinate":[102],"a":[104],"area":[106,127],"together":[107],"control":[111],"test":[112,119],"healthy":[114],"skin.":[115],"The":[116,196],"only":[117],"positive":[118],"was":[120,188],"(hard":[128],"erythema":[129],"at":[130,134],"24":[131],"hours).":[132],"Histology":[133],"72":[135],"hours":[136],"demonstrated":[137],"DISCUSSION:":[140],"Six":[141],"cases":[142,156],"induced":[146,173],"by":[147,174,205],"heparin":[150],"have":[151],"reported,":[153],"including":[154],"three":[155],"enoxaparin.":[158],"Two":[159],"pathophysiological":[160],"mechanisms":[161],"could":[162],"be":[163,203],"involved:":[164],"(i)":[165],"localized":[166],"heparin-dependent":[167],"platelet":[168],"aggregation,":[169],"or":[170],"(ii)":[171],"vasculitis":[172,187],"type":[175],"III":[176],"hypersensitivity":[177,194],"reaction.":[178,195],"In":[179],"our":[180],"case,":[181],"compatible":[189],"immune":[192,210],"complex":[193],"would":[202],"explained":[204],"enoxaparin-induced":[206],"preferential":[207],"deposit":[208],"complexes":[211],"vascular":[214],"turbulences":[215],"present":[216],"areas.":[219]},"counts_by_year":[{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}